Hinge Health (HNGE) EBIT Margin (2024 - 2026)

Hinge Health (HNGE) has 3 years of EBIT Margin data on file, last reported at 17.59% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin rose 698.0% year-over-year to 17.59%; the trailing twelve-month figure through Mar 2026 stood at 81.6% (down 8454.0% YoY), and the FY2025 full-year result was 92.94%, down 8477.0% from the prior year.
• EBIT Margin climbed to 17.59% in Q1 2026, from 15.96% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 17.83% in Q4 2024 to a low of 417.45% in Q2 2025.
• A 3-year average of 47.85% and a median of 3.39% in 2024 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin tumbled 39792 bps in 2025 and surged 698 bps in 2026, its largest moves.
• Tracing HNGE's EBIT Margin over 3 years: stood at 17.83% in 2024, then decreased by 10 bps to 15.96% in 2025, then advanced by 10 bps to 17.59% in 2026.
• Business Quant data shows HNGE's EBIT Margin at 17.59% in Q1 2026, 15.96% in Q4 2025, and 3.95% in Q3 2025.